01513.HK
Livzon Pharmaceutical Group, Inc.
HKSE · Healthcare · Drug Manufacturers - Specialty & Generic · CN
HKD 23.18
+4.32%Next report
Analyst consensus
- Next report date
- Mar 31, 2027
- EPS estimate
- HKD 0.41
- Revenue estimate
- HKD 2.8B
Latest reported
- Last report date
- Oct 23, 2026
- EPS actual
- HKD 0.47
- EPS estimate
- HKD 0.56
- Revenue actual
- HKD 2.7B
- Revenue estimate
- HKD 3.0B
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 0
- EPS misses (12Q)
- 2
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- -27.4%
- Revenue beats (12Q)
- 0
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Oct 23, 2026 | HKD 0.56 | HKD 0.47 | Miss -17.24% | HKD 2.7B |
| Aug 21, 2026 | HKD 0.74 | HKD 0.46 | Miss -37.51% | HKD 2.5B |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Mar 31, 2027